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TO THE EDITOR In vivo confocal laser scanning microscopy (CLSM) is a tool for obtaining ''optical biopsies'' of skin lesions at near histological resolution. Earlier investigations have suggested that this instrument may be useful as a surgical guide for the controlled excisions of cutaneous tumors and may be especially useful for lesions with poorly defined borders (e.g., lentigo maligna melanomas). In vivo CLSM for the microsurgery of basal cell carcinoma (Tannous et al., 2003; Marra et al., 2005) and malignant melanoma (Curiel-Lewandrowski et al., 2004; Chen et al., 2005) have been reported.
Currently, in vivo CLSM has been used in the reflectance mode. Tumor detection is based on differences in the refractive indices between normal and malignant tissues. However, exogenous contrast reagents may increase the detail of lesions for the demarcation of tumor margins. For example, Tannous et al. (2003) reported that aluminum chloride minimized the mismatch between the tissue and immersion medium refractive indices and improved the identification of basal cell carcinoma tumor margins in patients undergoing Mohs micrographic surgery.
In vivo CLSM can also be used in the fluorescence mode (Li et al., 2005) . ) were intravenously injected into tumor-bearing C57BL/6 mice (0.02 mg kg À1 ) and killed 16 hours later. The radioactivities of tissues were measured in a g-counter after first measuring the organ weights. Results shown are the means7SD of three mice per group and significant differences determined using the two-tailed Mann-Whitney U-test (*Po0.05).
Fluorescently labeled antibodies or peptides are examples of contrast reagents for use with in vivo CLSM. Peptides may be ideal for in vivo imaging compared to high-molecularweight antibodies due to the following: (a) peptides have quicker distribution times allowing rapid imaging, and (b) the short in vivo half-lives of peptides may ensure their efficient elimination, thus minimizing toxic side effects (Lundqvist and Tolmachev, 2002) .
Contrast reagents for the in vivo demarcation of melanoma margins are lacking. Hyaluronan (HA) is a glycosaminoglycan expressed by malignant melanomas. Karjalainen et al. (2000) reported that 100% of primary melanomas were stroma positive for HA and 70% of the same melanomas had HA associated with the tumor cell surfaces. Thus, HA may be a marker for melanomas. Pep-1 is an HA-binding peptide that binds strongly to cell surface HA but weakly to HA in the extracellular matrix (Zmolik and Mummert, 2005) . Therefore, Pep-1 may be a new contrast reagent for demarcating melanoma margins.
To evaluate the utility of Pep-1 as a contrast reagent, we conjugated tetramethylrhodamine isothiocyanate (TRITC) to Pep-1 (GAHWQFNALTVRGGGSY) or a scrambled control (WRHGFALT AVNQGGGSY) and engineered B16-F10 melanoma cells to express green fluorescent protein (GFP). All animal experiments were approved by the Institutional Review Board at the University of Texas Southwestern Medical Center.
We first investigated the pharmacokinetics and biodistributions of TRITC-Pep-1. As shown in Figure 1a , [ 125 I]TRITC-Pep-1 and the [ 125 I]TRITCscrambled control showed relatively rapid clearance and similar pharmacokinetics (Figure 1b) . The biodistribution of [ 125 I]TRITC-Pep-1 showed significantly higher binding to melanoma tumors compared with the [ 125 I] TRITC-scrambled control, whereas both peptides showed similar levels of binding to the other tissues (Figure 1c) . These results showed that TRITC-Pep-1 bound to B16-F10 tumors with high specificity. Next, we imaged tumors established in mouse ear skin under CLSM. GFP þ tumors were distinguish-able from the surrounding tissue by TRITC-Pep-1, but not by the TRITCscrambled control (Figure 2a ). Because the sizes of tumors exceeded the microscopic field of view, we created montages of tumor subimages. Again, TRITC-Pep-1 showed binding to the tumor but weak or no binding to uninvolved tissue, whereas the TRITCscrambled control showed little or no binding to either the tumor or the tissue (Figure 2b) . Importantly, TRITC-Pep-1 signals were useful for full thickness (B1.0 mm) tumor detection. The contrast-to-noise ratio for TRITC-Pep-1 was significantly greater than the TRITC-scrambled control, showing its potential utility to serve as a contrast reagent (Figure 2c) .
The merged images of the tumors (Figure 2a and b) highlighted that TRITC-Pep-1 staining was heterogeneous. We therefore made a comparison of fluorescent regions in three different tumors to assess TRITC-Pep-1 binding. We found variations in TRITC-Pep-1 intensities between different regions within the same tumor, but did not observe a correlation between the variations in TRITC-Pep-1 signals and different tumor regions (i.e., midtumor versus the tumor periphery). Because were acquired under CLSM for tumors B3.0 mm in diameter. Excitation for GFP was 488 nm and 543 nm for the TRITC-conjugated peptides. Fluorescence emissions were detected with water immersion objectives (original magnification Â 10) using sequential collections of the fluorescent signals. Three-dimensional image stacks were recorded (axial planes were separated by 1.10 mm) using a line average of four. Importantly, we obtained an ''optical biopsy'' for the full tumor thickness (B1.0 mm). Results are presented as the maximum intensity projections of horizontal (x-z planes) and vertical (y-z planes) scans (Bar ¼ 100 mm; original magnification Â 100). (b) Montages of tumor subimages were used to recreate the wide fields of view. Acquisition of the tumor subimages was performed as described above except that a line average of two was used instead of four to reduce potential photobleaching of adjacent sections during signal collection (Bar ¼ 1.5 mm; original magnification per sub image Â 100). (c) The TRITC fluorescent intensities in three different tumors established in three different mice was used to calculate the contrast-to-noise ratios. TRITC-Pep-1 (red) showed a significantly higher contrast-to-noise ratio compared with the TRITC-scrambled control (black). Results are presented as the means7SD (*Po0.05 by the two-tailed Mann-Whitney U-test). (d) The GFP (white) and TRITC-Pep-1 (red) mean fluorescent intensities in square 0.1 Â 0.1 mm regions of interest in 0.5 Â 0.5 mm fields of view for three different tumors established in three separate mice was evaluated. Five different fields per tumor were analyzed. Results showed marked variations of both GFP and TRITC-Pep-1 fluorescent intensities between different regions within the same tumor. On the other hand, TRITC-Pep-1 signals were detected in all of the GFP þ regions and vice versa.
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GFP and TRITC-Pep-1 fluorescent intensities were unequal in many of the tumor regions (Figure 2d ), the merged images were not uniformly yellow as expected for overlapping red and green colors of equal intensities. We therefore calculated overlap coefficients based on overlap subcoefficients that take into account the differences between GFP and TRITC-Pep-1 intensities. We found that the overlap coefficients for tumors 1, 2, and 3 were 0.976, 0.987, and 0.792, respectively. The large values for the overlap coefficients show that TRITC-Pep-1 had high co-registration with the GFP signals throughout most, if not all, of the tumor mass. How can we explain the heterogeneous binding of TRITC-Pep-1? Perhaps, the simplest explanation is that regions showing high levels of TRITC-Pep-1 staining correspond to regions with high HA concentrations, whereas low levels of TRITC-Pep-1 staining correspond to regions with low HA concentrations. It is well known that perfusion defects in tumors contribute to regional differences in hypoxia, anoxia, and acidosis due to a non-homogeneous vascular supply. Importantly, HA synthesis is a tightly regulated process that is modulated by the microenvironment. For example, lactate (a tumor metabolite) induces B16-F10 melanoma cells to increase their HA synthesis (Rudrabhatla et al., 2006) . Because lactate and other metabolites are not uniformly distributed throughout tumors (Walenta et al., 2000) , we speculate that high and low levels of TRITC-Pep-1 binding reflect regional differences in HA expression due to the heterogeneous microenvironment of the tumors. Can TRITC-Pep-1 be used for the mapping of melanomas? It will be necessary to compare the clinical, histological, and TRITC-Pep-1 margins in detail. Also, different human melanoma lines will need to be compared to assess the general utility of TRITC-Pep-1 to serve as a probe for demarcating melanoma margins under CLSM.
In conclusion, we have described a probe for demarcating melanoma margins in vivo. This work differs fundamentally from most other peptide contrast reagents, which have been developed for binding protein receptors (Becker et al., 2001; Ye et al., 2006; Zhang et al., 2006) or are fluorescent only after enzymatic cleavage (Mahmood et al., 1999; McIntyre et al., 2004) . Results herein suggest that carbohydrates can also serve as targets for in vivo imaging.
